{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T19:13:24Z","timestamp":1778354004244,"version":"3.51.4"},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T00:00:00Z","timestamp":1478131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>Physicians\u2019 use of prescription drug monitoring programs (PDMPs) varies by state. Among Maryland physicians, we sought to (1) estimate the PDMP impact on changes in opioid prescribing, (2) approximate the scope of PDMP utility and (3) determine the barriers to PDMP use after its 2013 implementation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Cross\u2010sectional postal survey linking responses to state records of PDMP registration and use, randomly sampling physicians within specialty and registration strata.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Maryland, USA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>A total of 1000 surveyed primary care, pain and emergency medicine physicians stratified into three subpopulations: PDMP non\u2010registrants, PDMP registrants who were non\u2010users and PDMP users; 405 respondents (44%) of 916 eligible physicians were analysed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Measurements<\/jats:title><jats:p>Primary outcome measure was PDMP use. Key predictors were clinic characteristics, including type of practice and number of patients prescribed opioids.<\/jats:p><\/jats:sec><jats:sec><jats:title>Findings<\/jats:title><jats:p>No response\u2010wave bias was identified. Seventy per cent of physicians believed PDMP access decreased their amount and increased their comfort level in prescribing opioids. Three\u2010fourths (74%) of PDMP users reported the data very useful for informing opioid prescribing, although one\u2010fifth (20%) reported difficulty accessing the data. Commonly reported barriers to PDMP use were lack of knowledge regarding its existence and registration process. In multivariable analysis after adjusting for key clinic characteristics, practicing at a managed care organization was associated with lower PDMP use [incidence rate ratio (IRR)\u00a0=\u00a00.19, 95% confidence interval (CI)\u00a0=\u00a00.05\u20130.73]. Conversely, physicians who prescribed opioids for more than 50 patients accessed the PDMP three times as often as those prescribing opioids for fewer than 10 patients monthly (IRR\u00a0=\u00a03.00, 95\u00a0% CI\u00a0=\u00a01.07\u20138.43).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this survey of Maryland, USA physicians, most participants reported that prescription drug monitoring programs (PDMPs) improved their opioid prescribing by decreasing prescription amounts and increasing comfort with prescribing opioids. Common barriers to PDMP use included not knowing about the program, registration difficulties and data access difficulties.<\/jats:p><\/jats:sec>","DOI":"10.1111\/add.13620","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T06:22:40Z","timestamp":1474611760000},"page":"311-319","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP)"],"prefix":"10.1111","volume":"112","author":[{"given":"Dora H.","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health  Baltimore MD USA"},{"name":"Center for Drug Safety and Effectiveness Johns Hopkins University  Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"Lucas","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health  Baltimore MD USA"},{"name":"Center for Drug Safety and Effectiveness Johns Hopkins University  Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene B.","family":"Murimi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health  Baltimore MD USA"},{"name":"Center for Drug Safety and Effectiveness Johns Hopkins University  Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Jackson","sequence":"additional","affiliation":[{"name":"Behavioral Health Administration, Maryland Department of Health and Mental Hygiene  Catonsville MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Baier","sequence":"additional","affiliation":[{"name":"Behavioral Health Administration, Maryland Department of Health and Mental Hygiene  Catonsville MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Frattaroli","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health  Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea C.","family":"Gielen","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health  Baltimore MD USA"},{"name":"Center for Injury Research and Policy Johns Hopkins University  Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patience","family":"Moyo","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Health Services Research, School of Pharmacy University of Maryland  Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Simoni\u2010Wastila","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Health Services Research, School of Pharmacy University of Maryland  Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Caleb","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health  Baltimore MD USA"},{"name":"Center for Drug Safety and Effectiveness Johns Hopkins University  Baltimore MD USA"},{"name":"Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine  Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,11,3]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e3182a95d86"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031914-122957"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12551"},{"key":"e_1_2_8_5_1","unstructured":"Center for Behavioral Health Statistics and Quality.Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and HealthHHS Publication No. SMA 15\u20104927 NSDUH Series H\u201050.2015. (Available at:http:\/\/www.samhsa.gov\/data\/)."},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6450a3"},{"key":"e_1_2_8_7_1","unstructured":"PDMP Center of Excellence at Brandeis University.PDMP prescriber use mandates: characteristics current status and outcomes in selected states.2016. Available at:http:\/\/www.pdmpassist.org\/pdf\/COE_documents\/Add_to_TTAC\/COE%20briefing%20on%20mandates%203rd%20revision.pdf(accessed 11 October 2016) (Archived athttp:\/\/www.webcitation.org\/6lBIZhACWon 11 October 2016)."},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.10.001"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1712"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1204493"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2004.04049.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6409a1"},{"key":"e_1_2_8_13_1","unstructured":"FinkleaK. SaccoL. N. BagalmanE.Prescription Drug Monitoring Programs. Congressional Research Service Report.2014. Available at:http:\/\/mchip.xykon\u2010llc.com\/sgp\/crs\/misc\/R42593.pdf(accessed 13 March 2016) (Archived athttp:\/\/www.webcitation.org\/6lCeBO2vDon 12 October 2016)."},{"key":"e_1_2_8_14_1","unstructured":"ClarkT. EadieJ. KnueP. KreinerP. StricklerG.Prescription drug monitoring programs: an assessment of the evidence for best practices. The Prescription Drug Monitoring Program Center of Excellence Heller School for Social Policy and Management Brandeis University.2012. Available at:http:\/\/www.pdmpassist.org\/pdf\/COE_documents\/Add_to_TTAC\/Brandeis_PDMP_Report.pdf(accessed 11 October 2016) (Archived athttp:\/\/www.webcitation.org\/6lBIZhACWon 11 October 2016)."},{"key":"e_1_2_8_15_1","unstructured":"National Alliance for Model State Drug Laws (NAMSDL).2015 Annual review of prescription monitoring programs.2015. Available at:http:\/\/www.namsdl.org\/library\/1810E284\u2010A0D7\u2010D440\u2010C3A9A0560A1115D7\/(accessed 13 March 2016) (Archived athttp:\/\/www.webcitation.org\/6lBOTUI9gon 11 October 2016)."},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2014.1085"},{"key":"e_1_2_8_17_1","unstructured":"Maryland Department of Health and Mental Hygiene.PDMP frequently asked questions.2016. Available at:http:\/\/bha.dhmh.maryland.gov\/pdmp\/Pages\/-PDMP_FAQs.aspx(accessed 13 March 2016) (Archived athttp:\/\/www.webcitation.org\/6l9kXDg3non 10 October 2016)."},{"key":"e_1_2_8_18_1","unstructured":"National Alliance for Model State Drug Laws (NAMSDL).PDMP Dates of Operation Table (March 2014). NAMSDL Prescription Drug Monitoring Programs Archive.2014. Available at:http:\/\/www.namsdl.org\/library\/580225E9\u2010E469\u2010AFA9\u201050E7579C1D738E71\/(accessed 13 March 2016) (Archived athttp:\/\/www.webcitation.org\/6lBFSLIAaon 11 October 2016)."},{"key":"e_1_2_8_19_1","unstructured":"National Alliance for Model State Drug Laws (NAMSDL).Recent legislative and regulatory trends in prescription monitoring programs. NAMSDL Prescription Drug Monitoring Programs Trends in PMPs.2014. Available 16 at:www.namsdl.org\/library\/D651C2DC\u2010B73E\u2010DC6A\u2010C450A4863CC1F73C\/(accessed 16 August 2016) (Archived athttp:\/\/www.webcitation.org\/6lBOTUI9gon 11 October 2016)."},{"key":"e_1_2_8_20_1","unstructured":"Prescription Drug Monitoring Program Center of Excellence at Brandeis University.Guidance on PDMP Best Practices Options for Unsolicited Reporting.2016. Available at:http:\/\/www.pdmpassist.org\/pdf\/COE_documents\/Add_to_TTAC\/Update%20to%20Brandeis%20COE%20Guidance%20on%20Unsolicited%20Reporting%20final.pdf(accessed 16 August 2016) (Archived athttp:\/\/www.webcitation.org\/6lBIZhACWon 11 October 2016)."},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000000268"},{"key":"e_1_2_8_22_1","volume-title":"Mail and Telephone Surveys: the Total Design Method","author":"Dillman D. A.","year":"1978"},{"key":"e_1_2_8_23_1","volume-title":"Stata Statistical Software: Release 12","author":"StataCorp L. P.","year":"2011"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/0163278713496565"},{"key":"e_1_2_8_25_1","volume-title":"The Prescription Opioid Epidemic: An Evidence\u2010Based Approach","author":"Alexander G. C.","year":"2015"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000000180"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2015.10.019"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-012-0250-2"},{"key":"e_1_2_8_29_1","unstructured":"Maryland Department of Health and Mental Hygiene.Maryland opioid overdose prevention plan.2013. Available at:http:\/\/bha.dhmh.maryland.gov\/OVERDOSE_PREVENTION\/Documents\/MarylandOpioidOverdosePreventionPlan2013.pdf(accessed 13 March 2016) (Archived athttp:\/\/www.webcitation.org\/6l9kXDg3non 10 October 2016)."},{"key":"e_1_2_8_30_1","unstructured":"National Alliance for Model State Drug Laws (NAMSDL).States that allow prescribers and\/or dispensers to appoint a delegate to access the PMP Compilation of Statutes. NAMSDL Prescription Drug Monitoring Programs Archive.2014. Available at:http:\/\/www.namsdl.org\/library\/BBB38C95-A57D\u201076AF\u20108DB22F9D99EFBA4C\/(accessed 13 March 2016) (Archived athttp:\/\/www.webcitation.org\/6lBFSLIAaon 11 October 2016)."},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/1525822X08317085"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.13620","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.13620","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.13620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T21:50:29Z","timestamp":1695505829000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.13620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1111\/add.13620"],"URL":"https:\/\/doi.org\/10.1111\/add.13620","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,3]]},"assertion":[{"value":"2016-03-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-09-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-11-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}